documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

4,226 rows where agency_id = "FDA" and posted_year = 2012 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: posted_month, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 5

posted_year 1

  • 2012 · 4,226 ✖

agency_id 1

  • FDA · 4,226 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2012-N-0002-0039 FDA FDA-2012-N-0002 Freedom of Information Summary NADA 141-068 BAYTRIL 100 Injectable Solution Supporting & Related Material Reference (internal unless indicated) 2012-12-31T05:00:00Z 2012 12     2012-12-31T16:35:08Z   0 0 09000064811a07bf
FDA-1975-N-0012-0196 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Citizen Petition from Ciba Specialty Chemicals Corporation Other Citizen Petition 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2017-11-22T17:13:28Z   0 0 09000064805c1b33
FDA-1975-N-0012-0197 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Acknowledgment Letter from FDA/DDM to Ciba Specialty Chemicals Corporation Other Acknowledgement Letter/Receipt 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2017-11-27T15:57:51Z   0 0 09000064805c1b34
FDA-1975-N-0012-0198 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Supplement from Ciba Specialty Chemicals Corporation Other Supplement (SUP) 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2017-11-22T17:41:18Z   0 0 09000064805c1b35
FDA-2012-S-1178-0015 FDA FDA-2012-S-1178 NDI 734, Heat-Killed Lactobacillus Plantarum L-137 (HK-LP), Immuno-LP20 from House Wellness Foods Corporation Other 75 Day PreMarket Notification 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2016-10-27T15:19:56Z   0 0 0900006481199880
FDA-2012-S-1178-0017 FDA FDA-2012-S-1178 NDI 736, Tall Oil Phytoesters from Forbes Medi-Tech Corporation Other 75 Day PreMarket Notification 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2016-10-27T15:19:56Z   0 0 0900006481199883
FDA-1980-N-0004-0008 FDA Over-the-Counter Ophthalmic Drug Products for Emergency First Aid Use; Proposed Amendment of Final Monograph for Over-the-Counter Opthalmic Drug Products FDA-1980-N-0004 Acknowledgement Letter to Ferenc Kuhn, M.D., Ph.D. and Wendell J. Scott M.D. Other Acknowledgement Letter/Receipt 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2012-12-31T19:33:40Z   0 0 090000648119e74e
FDA-2012-N-0002-0036 FDA FDA-2012-N-0002 Freedom of Information Summary ANADA 200-466 SPARMECTIN Plus Clorsulon Supporting & Related Material Freedom of Information Summary 2012-12-31T05:00:00Z 2012 12     2012-12-31T16:35:07Z   0 0 090000648114c76f
FDA-1980-N-0004-0007 FDA Over-the-Counter Ophthalmic Drug Products for Emergency First Aid Use; Proposed Amendment of Final Monograph for Over-the-Counter Opthalmic Drug Products FDA-1980-N-0004 Citizen Petition from Ferenc Kuhn, MD., Ph.D. and Wendell J. Scott M.D. Other Citizen Petition 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2024-11-12T05:09:22Z   1 0 090000648119e74c
FDA-2012-P-1265-0001 FDA FDA-2012-P-1265 Indicus Pharma LLC - Citzen Petition Other Citizen Petition 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2019-01-19T02:05:18Z   0 0 090000648119e750
FDA-2012-P-1265-0002 FDA FDA-2012-P-1265 Acknowledgement Letter to Indicus Pharma LLC Other Acknowledgement Letter/Receipt 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2012-12-31T19:12:37Z   0 0 090000648119e753
FDA-2012-N-0002-0032 FDA FDA-2012-N-0002 New Animal Drugs: Enrofloxacin; Melengestrol; Meloxicam; Pradofloxacin; Tylosin Rule Final Rule 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2012-12-31T15:19:06Z 2012-31397 0 0 09000064811a03c6
FDA-2012-E-1245-0001 FDA FDA-2012-E-1245 The Henry M. Jackson Foundation for the Advancement of Military Meicine (Finnegan, Henderson, et al) - Patent Extension Application Other Application 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2012-12-31T21:46:33Z   0 0 09000064811a0ce5
FDA-1975-N-0012-0194 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Citizen Petition from Bayer Corporation Other Citizen Petition 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2017-11-27T15:04:09Z   0 0 09000064805c1b30
FDA-2012-N-0002-0038 FDA FDA-2012-N-0002 Freedom of Information Summary NADA 141-346 OroCAM Supporting & Related Material Freedom of Information Summary 2012-12-31T05:00:00Z 2012 12     2012-12-31T16:35:08Z   0 0 09000064811a07bc
FDA-1975-N-0012-0221 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Supplement from Aplicare Inc. Other Supplement (SUP) 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2017-10-30T15:11:18Z   0 0 09000064805c1c9b
FDA-2012-N-0002-0034 FDA FDA-2012-N-0002 Freedom of Information Summary NADA 141-340 SKYCIS 100 Supporting & Related Material Freedom of Information Summary 2012-12-31T05:00:00Z 2012 12     2012-12-31T16:35:07Z   0 0 090000648114c01f
FDA-2012-E-1244-0002 FDA FDA-2012-E-1244 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2012-12-31T21:17:55Z   0 0 09000064811a0ce3
FDA-2012-N-0002-0035 FDA FDA-2012-N-0002 Freedom of Information Summary NADA 141-342 ALFAXAN Supporting & Related Material Freedom of Information Summary 2012-12-31T05:00:00Z 2012 12     2012-12-31T16:35:07Z   0 0 090000648114c76d
FDA-2012-N-0002-0033 FDA FDA-2012-N-0002 Freedom of Information Summary NADA 141-339 OVUGEL Supporting & Related Material Freedom of Information Summary 2012-12-31T05:00:00Z 2012 12     2012-12-31T16:35:07Z   0 0 090000648114c01d
FDA-2012-P-0661-0003 FDA FDA-2012-P-0661 Interim Response Letter from FDA CDER to Sandoz, Inc. Other Letter(s) 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2019-03-14T17:26:53Z   0 0 09000064811a0c2e
FDA-1975-N-0012-0195 FDA Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 Acknowledgment Letter from FDA/DDM to Bayer Corporation Other Acknowledgement Letter/Receipt 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2017-10-24T19:34:23Z   0 0 09000064805c1b31
FDA-2012-S-1178-0019 FDA FDA-2012-S-1178 NDI 738, Antrodia Cinnamomea Extract from WinPal LLC Other 75 Day PreMarket Notification 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2016-10-27T15:19:56Z   0 0 0900006481199885
FDA-2012-P-1267-0001 FDA FDA-2012-P-1267 Xspire Pharma, LLC - Citizen Petition Other Citizen Petition 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2024-11-12T05:11:10Z   1 0 090000648119ff73
FDA-2010-P-0188-0016 FDA FDA-2010-P-0188 AXIN, Veltrop & Harkrider LLP (Actavis Elizabeth LLC) - Withdrawal of Citizen Petition Other Withdrawal 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2012-12-31T17:34:48Z   0 0 09000064811a0997
FDA-2012-S-1178-0016 FDA FDA-2012-S-1178 NDI 735, Euphovida (3-Phytase), EUPHOVIDA TM from DSM Food Specialties Other 75 Day PreMarket Notification 2012-12-31T05:00:00Z 2012 12     2016-10-27T15:19:56Z   0 0 0900006481199882
FDA-2012-E-1244-0001 FDA FDA-2012-E-1244 The Henry M. Jackson Foundation for the Advancement of Military Meicine (Finnegan, Henderson, et al) - Patent Extension Application Other Application 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2012-12-31T21:39:13Z   0 0 09000064811a0cc1
FDA-2012-N-0002-0037 FDA FDA-2012-N-0002 Freedom of Information Summary NADA 141-344 VERAFLOX Suspension for Cats Supporting & Related Material Freedom of Information Summary 2012-12-31T05:00:00Z 2012 12     2012-12-31T16:35:08Z   0 0 09000064811a07b7
FDA-2012-S-1178-0018 FDA FDA-2012-S-1178 NDI 737, Syringa Vulgaris Extract, I.R.B. lstituto di Ricerche Biotecnologiche S.p.A. Other 75 Day PreMarket Notification 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2016-10-27T15:19:56Z   0 0 0900006481199884
FDA-2012-E-1245-0002 FDA FDA-2012-E-1245 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2012-12-31T21:46:33Z   0 0 09000064811a0ce7
FDA-2012-P-1267-0002 FDA FDA-2012-P-1267 Acknowledgement Letter to Xspire Pharma, LLC Other Acknowledgement Letter/Receipt 2012-12-31T05:00:00Z 2012 12 2012-12-31T05:00:00Z   2012-12-31T19:41:32Z   0 0 090000648119ff76
FDA-2012-P-1259-0001 FDA FDA-2012-P-1259 Hyman Phelps McNamara PC - Citizen Petition Other Citizen Petition 2012-12-30T05:00:00Z 2012 12 2012-12-30T05:00:00Z   2024-11-12T05:11:55Z   1 0 090000648119d635
FDA-2012-P-1259-0002 FDA FDA-2012-P-1259 Acknowledgement Letter to Hyman, Phelps & McNamara, PC Other Acknowledgement Letter/Receipt 2012-12-30T05:00:00Z 2012 12 2012-12-30T05:00:00Z   2012-12-31T01:04:14Z   0 0 090000648119d736
FDA-2011-E-0133-0007 FDA FDA-2011-E-0133 Letter to U. S. Patent and Trademark Office Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2024-03-13T11:51:10Z   0 0 090000648119d5e1
FDA-2012-E-1237-0001 FDA FDA-2012-E-1237 Genentech, Inc. (Morrison & Foerster LLP) - Patent Extension Application Other Application 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T16:13:29Z   0 0 090000648119df04
FDA-2012-E-1236-0001 FDA FDA-2012-E-1236 Genentech, Inc. (Morrison & Foerster LLP) - Patent Extension Application Other Application 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T14:44:12Z   0 0 090000648119dbad
FDA-1995-S-0036-0135 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Resuscitation Outcomes Consortium (ROC) re IND 110280, British Columbia, Canada Public Disclosure Material Report 63 - Report Other Report 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2014-11-28T19:44:04Z   0 0 090000648118f830
FDA-2011-E-0153-0007 FDA FDA-2011-E-0153 FDA\CDER to U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T14:09:25Z   0 0 090000648119d582
FDA-2010-E-0399-0008 FDA FDA-2010-E-0399 FDA\CDER to U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T14:49:24Z   0 0 090000648119d5de
FDA-2007-E-0482-0009 FDA FDA-2007-E-0482 FDA/CDER to U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T12:41:20Z   0 0 090000648119d087
FDA-2007-E-0278-0013 FDA FDA-2007-E-0278 FDA/CDER to Covington & Burling LLP (Merck & Co., Inc.) - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T14:23:52Z   0 0 090000648119d5dc
FDA-2012-E-1235-0002 FDA FDA-2012-E-1235 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T14:01:20Z   0 0 090000648119d26b
FDA-2012-E-1237-0002 FDA FDA-2012-E-1237 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T16:13:31Z   0 0 090000648119e02b
FDA-2011-E-0136-0008 FDA FDA-2011-E-0136 Letter to U. S. Patent and Trademark Office Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2024-03-13T11:49:37Z   0 0 090000648119d5e4
FDA-1995-S-0036-0136 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 University of Texas Health Science Center at Houston re IND 14929, University of Alabama Public Disclosure Material Report 64 - Report Other Report 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2014-11-28T19:44:18Z   0 0 090000648118f832
FDA-2010-E-0663-0006 FDA FDA-2010-E-0663 FDA/CDER to U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T13:09:35Z   0 0 090000648119d090
FDA-1995-S-0036-0137 FDA Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 Rampart Neurological Emergencies Treatment Trials Neuro Emergencies Research, Community Consultion and Public Disclosure IND 102254 Report 65 - Report Other Report 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2014-11-28T19:44:31Z   0 0 090000648119e1fd
FDA-2012-E-1241-0003 FDA FDA-2012-E-1241 Abbott Cardiovascular Systems Inc. (Baker Botts, LLP) - Supplement Other Supplement (SUP) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T17:24:52Z   0 0 090000648119e0e9
FDA-2012-V-1222-0002 FDA FDA-2012-V-1222 Acknowledgement Letter to Simply Automation Other Acknowledgement Letter/Receipt 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T15:16:11Z   0 0 090000648118faf9
FDA-2012-E-1234-0001 FDA FDA-2012-E-1234 Mitsubishi Tenabe Pharma Corp. (Finnegan, Henderson, Farabow, Garrett & Dunner LLP) - Patent Extension Application Other Application 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T13:10:24Z   0 0 090000648119d265
FDA-2012-E-1236-0002 FDA FDA-2012-E-1236 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T14:44:12Z   0 0 090000648119dbaf
FDA-2012-E-1241-0001 FDA FDA-2012-E-1241 Abbott Cardiovascular Systems Inc. (Baker Botts, LLP) - Patent Extension Application Other Application 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T17:24:50Z   0 0 090000648119e0e4
FDA-2012-E-1243-0002 FDA FDA-2012-E-1243 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T21:50:47Z   0 0 090000648119eb02
FDA-2012-E-1235-0001 FDA FDA-2012-E-1235 Genentech, Inc. (Morrison & Foerster LLP) - Patent Extension Application Other Application 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T14:01:19Z   0 0 090000648119d269
FDA-2012-V-1222-0001 FDA FDA-2012-V-1222 Simply Automation - Application for Variance Other Application for Variance (VAR) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T15:16:10Z   0 0 090000648118faa9
FDA-2012-E-1234-0002 FDA FDA-2012-E-1234 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T13:10:25Z   0 0 090000648119d267
FDA-2011-E-0139-0007 FDA FDA-2011-E-0139 FDA/CDER to U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T13:00:15Z   0 0 090000648119d08b
FDA-2011-E-0371-0007 FDA FDA-2011-E-0371 FDA/CDER to U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T13:21:29Z   0 0 090000648119d57c
FDA-2011-E-0168-0007 FDA FDA-2011-E-0168 Letter to U. S. Patent and Trademark Office Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2024-03-13T11:33:47Z   0 0 090000648119d580
FDA-2010-E-0049-0007 FDA FDA-2010-E-0049 FDA/CDER to U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T12:50:18Z   0 0 090000648119d089
FDA-2011-E-0379-0007 FDA FDA-2011-E-0379 FDA/CDER to U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T13:27:04Z   0 0 090000648119d57e
FDA-2012-E-1243-0001 FDA FDA-2012-E-1243 Durand Wayland Inc. (Altera Law Group LLC) - Patent Extension Application Other Application 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T21:50:46Z   0 0 090000648119eadf
FDA-2012-E-1241-0002 FDA FDA-2012-E-1241 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-28T05:00:00Z 2012 12 2012-12-28T05:00:00Z   2012-12-28T17:24:51Z   0 0 090000648119e0e6
FDA-2012-S-1178-0009 FDA FDA-2012-S-1178 NDI 727 17a-Hydroxypregna-1,4-Diene-3,20-Dione 1,4-Diene from Proprietary Wellness Other 75 Day PreMarket Notification 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2016-10-27T15:19:55Z   0 0 0900006480fac72b
FDA-2012-E-1246-0001 FDA FDA-2012-E-1246 Medtronic, Inc. (Sterne Kessler Goldstein & Fox PLLC) - Patent Extension Application Other Application 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T23:16:14Z   0 0 090000648119cae1
FDA-2001-V-0062-0009 FDA SKI Dazzle Laser Show FDA-2001-V-0062 FDA/CDRH to DayStar Lasers International, LLC - Approval for Variance Other Approval for Variance (VRA) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T16:35:26Z   0 0 090000648119b78c
FDA-2012-E-1233-0002 FDA FDA-2012-E-1233 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-28T00:24:28Z   0 0 090000648119ceef
FDA-2012-E-1226-0002 FDA FDA-2012-E-1226 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T23:14:08Z   0 0 090000648119ce85
FDA-2012-E-1232-0002 FDA FDA-2012-E-1232 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T23:56:54Z   0 0 090000648119ce89
FDA-2012-E-1232-0001 FDA FDA-2012-E-1232 Arena Pharmaceuticals, Inc. (Finnegan Henderson LLP) - Patent Extension Application Other Application 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T23:56:33Z   0 0 090000648119ce87
FDA-2012-S-1178-0011 FDA FDA-2012-S-1178 NDI 729, HT 1001: Panax quinquefolius (American ginseng) from Afexa Life Sciences, Inc. Other 75 Day PreMarket Notification 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2016-10-27T15:19:55Z   0 0 0900006480fac757
FDA-2012-S-1178-0010 FDA FDA-2012-S-1178 NDI 728 Terminalia chebula from Hikmeth Corporation Other 75 Day PreMarket Notification 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2016-10-27T15:19:55Z   0 0 0900006480fac748
FDA-2011-E-0152-0007 FDA FDA-2011-E-0152 FDA\CDER to United States Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T18:17:27Z   0 0 090000648119c9b4
FDA-2010-E-0334-0009 FDA FDA-2010-E-0334 FDA\CDER to U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T15:16:22Z   0 0 090000648119c5b0
FDA-2010-E-0662-0006 FDA FDA-2010-E-0662 FDA\CDER to United States Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T19:53:47Z   0 0 090000648119cadb
FDA-2011-N-0899-0003 FDA FDA-2011-N-0899 Finding of no Significant Impact for Genetically Engineered Atlantic Salmon (AquAdvantage Salmon) Notice Availability of Document 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z 2013-04-27T03:59:59Z 2014-11-14T03:06:12Z   0 0 090000648119d263
FDA-2012-E-1247-0002 FDA FDA-2012-E-1247 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T22:11:52Z   0 0 090000648119ce81
FDA-2010-E-0659-0008 FDA FDA-2010-E-0659 FDA\CDER to U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T14:53:05Z   0 0 090000648119c5ac
FDA-2011-E-0246-0007 FDA FDA-2011-E-0246 FDA\CDER to U.S. Patent and Trademark Office Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T16:46:12Z   0 0 090000648119c8d0
FDA-2011-E-0245-0007 FDA FDA-2011-E-0245 Letter to U. S. Patent and Trademark Office Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2024-03-13T11:31:53Z   0 0 090000648119c8ce
FDA-2011-E-0389-0008 FDA FDA-2011-E-0389 FDA\CDER to U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T15:51:29Z   0 0 090000648119c7d6
FDA-2012-S-1178-0014 FDA FDA-2012-S-1178 NDI 733, E. Coli Strain Nissle 1917 and Mutaflor from Medical Futures Inc. Other 75 Day PreMarket Notification 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2016-10-27T15:19:56Z   0 0 09000064811961c4
FDA-2012-E-1246-0002 FDA FDA-2012-E-1246 U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T21:16:32Z   0 0 090000648119cc3c
FDA-2012-V-1078-0003 FDA FDA-2012-V-1078 FDA/CDRH to Nicky-B Entertainment - Approval for Variance Other Approval for Variance (VRA) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T17:10:11Z   0 0 090000648119b800
FDA-2011-E-0380-0008 FDA FDA-2011-E-0380 FDA\CDER to U.S. Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T15:45:07Z   0 0 090000648119c5b5
FDA-2011-E-0113-0007 FDA FDA-2011-E-0113 FDA\CDER to United States Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T20:10:42Z   0 0 090000648119cadd
FDA-2012-S-1178-0012 FDA FDA-2012-S-1178 NDI 731, 3,5-Diiodo-L-Thryonine and Proprietary Wellness Other 75 Day PreMarket Notification 2012-12-27T05:00:00Z 2012 12 2011-10-05T04:00:00Z   2016-10-27T15:19:55Z   0 0 09000064811961bd
FDA-2011-E-0156-0007 FDA FDA-2011-E-0156 Letter to U. S. Patent and Trademark Office Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2024-03-13T11:35:54Z   0 0 090000648119c23a
FDA-2011-E-0114-0007 FDA FDA-2011-E-0114 Letter to U. S. Patent and Trademark Office Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2024-03-13T11:58:33Z   0 0 090000648119c7dd
FDA-2011-E-0014-0007 FDA FDA-2011-E-0014 Letter to U. S. Patent and Trademark Office Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2024-03-13T12:03:47Z   0 0 090000648119c23f
FDA-2010-E-0333-0009 FDA FDA-2010-E-0333 FDA\CDER to U.S. Patent and Trademark Office Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T15:24:03Z   0 0 090000648119c5b2
FDA-2012-D-1197-0005 FDA FDA-2012-D-1197 The Honorable Pete Olson et al to the Commissioner, FDA - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2013-02-28T21:04:16Z   0 0 090000648119b8ac
FDA-2010-E-0660-0007 FDA FDA-2010-E-0660 FDA\CDER to U.S. Patent and Trademark Office - Lettero Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T15:02:27Z   0 0 090000648119c5ae
FDA-2012-P-1180-0003 FDA FDA-2012-P-1180 Lannett Company, Inc. - Amendment Other Amendment 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-28T02:52:05Z   0 0 090000648119cd8a
FDA-2012-E-1247-0001 FDA FDA-2012-E-1247 Arena Pharmaceuticals Inc. (Finnegan, Henderson, Farabow, Garrett & Dunner, LLP) - Patent Extension Application Other Application 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T22:11:52Z   0 0 090000648119cde1
FDA-2012-E-1233-0001 FDA FDA-2012-E-1233 Toshiaki Miyake, et al (Wenderoth, Lind & Ponack LLP) - Patent Extension Application Other Application 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-28T00:24:28Z   0 0 090000648119ceed
FDA-2011-E-0141-0008 FDA FDA-2011-E-0141 Letter to U. S. Patent and Trademark Office Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2024-03-13T12:14:04Z   0 0 090000648119ca05
FDA-2012-E-1226-0001 FDA FDA-2012-E-1226 LEO Laboratories (Edwards, Wildman, Palmer LLP) - Patent Extension Application Other Application 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T23:11:19Z   0 0 090000648119ce83
FDA-2010-E-0661-0007 FDA FDA-2010-E-0661 FDA\CDER to United States Patent and Trademark Office - Letter Other Letter(s) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T19:42:58Z   0 0 090000648119ca07
FDA-2012-V-1008-0003 FDA FDA-2012-V-1008 FDA/CDRH to Sound and Lighting Designs - Approval for Variance Other Approval for Variance (VRA) 2012-12-27T05:00:00Z 2012 12 2012-12-27T05:00:00Z   2012-12-27T17:18:33Z   0 0 090000648119b804

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);